3′,4′-Dihydroxyflavonol attenuates spatial learning and memory impairments in global cerebral ischemia

Nutritional Neuroscience

Volumn 20, Issue 2, 2017, Pages 119-126

  Oz, Mehmet ^a   Demir, Enver Ahmet ^a   Caliskan, Merve ^a   Mogulkoc, Rasim ^a   Baltaci, Abdulkerim Kasım ^a   Nurullahoglu Atalik, K Esra ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Anxiety like behavior; DiOHF; Learning and memory; Stroke

Indexed keywords

3′,4′ DIHYDROXYFLAVONOL; FLAVONOL DERIVATIVE; UNCLASSIFIED DRUG; 3',4'-DIHYDROXYFLAVONOL; ANTIOXIDANT; ANXIOLYTIC AGENT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CAROTID ARTERY FLOW; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; HEART PROTECTION; LOCOMOTION; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; REPERFUSION INJURY; SPATIAL LEARNING; SPATIAL MEMORY; SWIMMING; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING DISORDERS; MEMORY; MEMORY DISORDERS; PATHOPHYSIOLOGY; PATTERN RECOGNITION; PREVENTION AND CONTROL; RANDOMIZATION; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIOXIDANTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FLAVONOLS; INJECTIONS, INTRAPERITONEAL; LEARNING DISORDERS; MALE; MEMORY; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; PATTERN RECOGNITION, PHYSIOLOGICAL; RANDOM ALLOCATION; RATS, WISTAR; REPERFUSION INJURY; SPATIAL LEARNING; TIME FACTORS;

EID: 84978531959     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000159     Document Type: Article

References (35)

1. Roine RO. Global cerebral ischemia. In:Fisher M, Bogouslavsky J, (eds.) Current review of cerebrovascular disease. Philadelphia:Current Medicine, 1997. p. 159–77.
2. Garcia JH. The evolution of brain infarcts. A review. J Neuropathol Exp Neurol 1992;51(4):387–93. doi:10.1097/00005072-199207000-00001
3. Kirino T. Delayed neuronal death. Neuropathology 2000;20(Suppl):S95–7. doi:10.1046/j.1440-1789.2000.00306.x
4. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999;79(4):1431–568.
5. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982;239(1):57–69. doi:10.1016/0006-8993(82)90833-2
6. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982;297(5868):681–3. doi:10.1038/297681a0
7. Block F. Global ischemia and behavioural deficits. Prog Neurobiol 1999;58(3):279–95. doi:10.1016/S0301-0082(98)00085-9
8. Hartman RE, Lee JM, Zipfel GJ, Wozniak DF. Characterizing learning deficits and hippocampal neuron loss following transient global cerebral ischemia in rats. Brain Res 2005;1043(1–2):48–56. doi:10.1016/j.brainres.2005.02.030
9. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region:enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6(10):2950–67.
10. Middleton E, Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells:implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52(4):673–751.
11. Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 2004;200(12):1667–72. doi:10.1084/jem.20040819
12. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids:a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74(4):418–25.
13. Zhao G, Zang SY, Jiang ZH, Chen YY, Ji XH, Lu BF, et al. Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model. J Nutr Biochem 2011;22(10):929–36. doi:10.1016/j.jnutbio.2010.07.014
14. Crozier A, Burns J, Aziz AA, Stewart AJ, Rabiasz HS, Jenkins GI, et al. Antioxidant flavonols from fruits, vegetables and beverages:measurements and bioavailability. Biol Res 2000;33(2):79–88. doi:10.4067/S0716-97602000000200007
15. Chan EC, Drummond GR, Woodman OL. 3′,4′-dihydroxyflavonol enhances nitric oxide bioavailability and improves vascular function after ischemia and reperfusion injury in the rat. J Cardiovasc Pharmacol 2003;42(6):727–35. doi:10.1097/00005344-200312000-00006
16. Wang S, Dusting GJ, May CN, Woodman OL. 3′,4′-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. Br J Pharmacol 2004;142(3):443–52. doi:10.1038/sj.bjp.0705815
17. Roulston CL, Callaway JK, Jarrott B, Woodman OL, Dusting GJ. Using behaviour to predict stroke severity in conscious rats:post-stroke treatment with 3′,4′-dihydroxyflavonol improves recovery. Eur J Pharmacol 2008;584(1):100–10. doi:10.1016/j.ejphar.2008.01.046
18. Singh DP, Chopra K. Verapamil augments the neuroprotectant action of berberine in rat model of transient global cerebral ischemia. Eur J Pharmacol 2013;720(1–3):98–106. doi:10.1016/j.ejphar.2013.10.043
19. Karakas A, Coskun H, Kaya A, Kucuk A, Gunduz B. The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. Behav Brain Res 2011;222(1):141–50. doi:10.1016/j.bbr.2011.03.029
20. Kanhere R, Anjana A, Anbu J, Sumithra M, Ahamed N. Neuroprotective and antioxidant potential of terpenoid fraction from Hygrophila auriculata against transient global cerebral ischemia in rats. Pharm Biol 2013;51(2):181–9. doi:10.3109/13880209.2012.716851
21. Milot M, Plamondon H. Ischemia-induced hyperactivity:effects of dim versus bright illumination on open-field exploration and habituation following global ischemia in rats. Behav Brain Res 2008;192(2):166–72. doi:10.1016/j.bbr.2008.03.044
22. Plamondon H, Khan S. Characterization of anxiety and habituation profile following global ischemia in rats. Physiol Behav 2005;84(4):543–52. doi:10.1016/j.physbeh.2005.02.001
23. Block F, Schwarz M. Dextromethorphan reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res 1996;741(1–2):153–9. doi:10.1016/S0006-8993(96)00916-X
24. Karasawa Y, Araki H, Otomo S. Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils. Stroke 1994;25(3):645–50. doi:10.1161/01.STR.25.3.645
25. Hamadate N, Yamaguchi T, Sugawara A, Togashi H, Izumi T, Yoshida T, et al. Liposome-encapsulated hemoglobin ameliorates impairment of fear memory and hippocampal dysfunction after cerebral ischemia in rats. J Pharmacol Sci 2010;114(4):409–19. doi:10.1254/jphs.10207FP
26. Girbovan C, Morin L, Plamondon H. Repeated resveratrol administration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav Pharmacol 2012;23(1):1–13. doi:10.1097/FBP.0b013e32834eafa3
27. Vorhees CV, Williams MT. Morris water maze:procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006;1(2):848–58. doi:10.1038/nprot.2006.116
28. Cheng O, Li Z, Han Y, Jiang Q, Yan Y, Cheng K. Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis. Brain Res 2012;1470:111–8. doi:10.1016/j.brainres.2012.06.026
29. Hu X, Zhang Y, Li W, Liu J, Li Y. Preconditioning with sevoflurane ameliorates spatial learning and memory deficit after focal cerebral ischemia-reperfusion in rats. Int J Dev Neurosci 2013;31(5):328–33. doi:10.1016/j.ijdevneu.2013.04.004
30. Han B, Wang Q, Cui G, Shen X, Zhu Z. Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia. Neurochem Int 2011;58(2):224–33. doi:10.1016/j.neuint.2010.12.008
31. Wang S, Dusting GJ, Woodman OL, May CN. Selective vasodilator and chronotropic actions of 3′,4′-dihydroxyflavonol in conscious sheep. Eur J Pharmacol 2004;491(1):43–51. doi:10.1016/j.ejphar.2004.03.012
32. Wang S, Fei K, Xu YW, Wang LX, Chen YQ. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats. Chin Med J 2009;122(1):61–7.
33. Qin CX, Williams SJ, Woodman OL. Antioxidant activity contributes to flavonol cardioprotection during reperfusion of rat hearts. Free Radic Biol Med 2011;51(7):1437–44. doi:10.1016/j.freeradbiomed.2011.07.003
34. Leo CH, Hart JL, Woodman OL. 3′,4′-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PLoS One 2011;6(6):e20813. doi:10.1371/journal.pone.0020813
35. Woodman OL, Chan E. Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 2004;31(11):786–90. doi:10.1111/j.1440-1681.2004.04072.x